🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

An AI-powered model using multiple datasets improves the prediction of how patients with muscle-invasive bladder cancer will respond to chemotherapy, according to a study led by Drs. Bishoy Faltas (Dr. Bishoy M. Faltas) and Fei Wang (Fei Wang). Full story: bit.ly/41QAe7I

Members of our #GU team attended the PSMA and Beyond Conference last month, where they presented on the latest prostate-specific membrane antigen (#PSMA) #research coming out of Weill Cornell Medicine. Read more here: bit.ly/4jDPOJL #PSMAandBeyond2025

Dr. Jim Hu (Jim Hu) discusses #research showing that transperineal #ProstateCancer biopsies were superior to the transrectal approach in detecting #cancer: bit.ly/42H9zJy (cc: @medscape)

National Cancer Institute Grant Funds Prostate Cancer Imaging Study news.weill.cornell.edu/news/2025/05/n… Weill Cornell Medicine Urology WCM GU Cancer

Members of our #GU team describe the latest advances in prostate-specific membrane antigen (#PSMA)-targeted radionuclide therapies for treating #ProstateCancer at various stages: bit.ly/4jxKUP2 (cc: Scott Tagawa Samuel Ruder Andres Ricaurte Fajardo Sandra Huicochea Castellanos)

Clinical research Weill Cornell Medicine NewYork-Presbyterian is dedicated to innovating, inspiring and transforming lives. On #ClinicalTrialsDay, some of our team members who support clinical research are sharing how we are Powered By Purpose. #CTD2025 ACRP - Assoc. of Clinical Research Profession

From #AUA25: Scott Tagawa highlighted the benefits of beta and alpha emitters for the management of metastatic castration-resistant #ProstateCancer bit.ly/3SnDwJV

Watch Scott Tagawa discuss the benefits and importance of #ClinicalTrial participation in #cancer care: bit.ly/4kGeySg (cc: CURE Today)

Live at #ASCO25: Dr. Bishoy Faltas (Dr. Bishoy M. Faltas) presented results from the CLONEVO #ClinicalTrial for #BladderCancer that he led with other Weill Cornell Medicine #GU team members bit.ly/3Z67KoD

Watch Dr. Bishoy Faltas (Dr. Bishoy M. Faltas) discuss #research he presented at #ASCO25 evaluating abemaciclib for certain patients with muscle-invasive #BladderCancer and how this study offers hope for this patient population bit.ly/3Z67KoD

New York ➡️ Chicago! Excited to see some of our Weill Cornell Medicine @NYPHospital team members at #ASCO25, ready to connect and share insights! Weill Cornell Medicine Meyer Cancer Center WCMHemOncFellow WCM Lung Cancer WCM GI Cancer WCM GU Cancer Weill Cornell Breast Center WCM Cutaneous Oncology

Dr. Valentina Marulanda-Corzo (Valentina Marulanda, MD) shared Weill Cornell Medicine NewYork-Presbyterian #research at #ASCO25 looking at the use of #PSMA PET imaging to assess treatment response in metastatic castration-resistant #ProstateCancer patients: bit.ly/3HiDvVy

Dr. Valentina Marulanda-Corzo (Valentina Marulanda, MD) with her Weill Cornell Medicine #ASCO25 poster discussing PSMA-targeted therapy for metastatic castration-resistant #ProstateCancer bit.ly/4jzqFzj

Honored to present our work at #ASCO25 and to be part of the incredible Weill Cornell Medicine and NewYork-Presbyterian family. Grateful for the opportunity to share our research on #PSMA PET imaging in mCRPC. Let’s keep pushing the boundaries of cancer care! 💪☢️ #Theranostics #MolecularImaging

Dr. Cora Sternberg (Cora Sternberg) was part of a global long-term follow-up study looking at the use of radium-223 for metastatic castration-resistant #ProstateCancer. bit.ly/4jrERuu #ASCO25

Grateful for the opportunity to present our CLONEVO investigator-initiated trial (IIT) in bladder cancer at ASCO #ASCO2025. Here are some lessons I learned along the way: Investigator-initiated trials (IITs) are essential. IITs are clinical trials independently designed and led

Dr. Bishoy Faltas (Dr. Bishoy M. Faltas) was involved in #research showing the potential of using deep learning models to predict treatment response in patients with muscle-invasive #BladderCancer: bit.ly/43NMyGC

.Scott Tagawa is leading a #ClinicalTrial evaluating a new therapy alone or in combination with other therapies for patients with metastatic castration-resistant #ProstateCancer. Learn more about the potential outcomes: bit.ly/4jm6eps

Honored to host CancerCast for Weill Cornell Medicine There is so much to learn and so much to talk about! Available on Apple Podcast, Spotify, or wherever you listen to podcasts! bit.ly/45BV0u0

#SNMMI2025 was a dream ✨ 🏆 Young Investigator Award 🏆 Inaugural Arthur M. Weis, PhD, Award 🏆 Travel Award Grateful beyond words to Divya Yadav MD Andres Ricaurte Fajardo Sandra Huicochea Castellanos Scott Tagawa Dr. Joseph Osborne + the whole WCM Molecular Imaging and Therapeutics team 💛 Weill Cornell Medicine Radiology WCM GU Cancer